• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CDC guidance for use pneumonia vaccine during H1N1 pandemic

Siegfried X

Well-known member
The CDC did not change their previous recommendations for use of pneumonia vaccine (PPSV23). However they added an emphasis because of problems one group had with H1N1.

CDC pneumonia vaccine guidance during H1N1 pandemic

All people who have existing indications for PPSV23 should continue to be vaccinated according to current ACIP recommendations during the outbreak of novel influenza A(H1N1). Emphasis should be placed on vaccinating people aged less than 65 years who have established high-risk conditions because PPSV23 coverage among this group is low and because people in this group appear to be overrepresented among severe cases of novel influenza A (H1N1) infection, based on currently available data.

Use of PPSV23 among people without current indications for vaccination is not recommended at this time. This recommendation may be revised as the epidemiology and clinical presentation of novel influenza A (H1N1) virus infection as well as the frequency and severity of secondary pneumococcal infections are better understood.

U.S. ACIP recommendations for use of pneumococcal polysaccacharide vaccine - Pneumococcal polysaccharide vaccine (PPSV23)

Universal vaccination: All adults 65 years of age and older

[or]

Medical Indications:
Persons 2 through 64 years of age who have one or more of the following long-term health problems:

  • chronic cardiovascular disease (congestive heart failure and cardiomyopathies)
  • chronic pulmonary disease including chronic obstructive pulmonary disease and emphysema
  • diabetes mellitus
  • alcoholism
  • chronic liver disease, including cirrhosis
  • cerebrospinal fluid leaks
  • functional or anatomic asplenia including sickle cell disease and splenectomy
  • immunocompromising conditions including HIV infection, leukemia, lymphoma, Hodgkin?s disease, multiple myeloma, generalized malignancy, chronic renal failure, nephrotic syndrome; those receiving immunosuppressive chemotherapy (including corticosteroids); and those who have received an organ or bone marrow transplant

[or]

Adults 19 through 64 years of age who:

  • smoke cigarettes
  • have asthma
 
Re: CDC guidance for use pneumonia vaccine during H1N1 pandemic

Does anyone know why they don't recommend this vax for children with asthma??? :( I'm very concerned about my child and can't get a doc (in GA) to vax him.
 
Back
Top